CBIS researchers have forged strong collaborations with several institutions to advance discovery in therapeutics, neurodegenerative and cardiovascular diseases, biomanufacturing, and more.
CBIS is a member of the National Institute for Innovation in Manufacturing Biopharmaceuticals, and is developing new methodologies in Advanced Manufacturing of Biotechnology diagnostic and therapeutic technologies. The collaboration includes industry, academia, nonprofit organizations, and federal agencies. Research is focused on developing rapid, flexible, and cost-efficient biopharmaceutical manufacturing technologies.
CBIS has a longstanding relationship with The Icahn School of Medicine at Mount Sinai School of Medicine (ISMMS) that encompasses both research and education. The Mount Sinai and Rensselaer Collaborative Center for Research Innovation and Entrepreneurship is the hub for these joint efforts, with the Mount Sinai Institute of Technology functioning as the primary partnership locus at Mount Sinai. Complementary research programs involving Mount Sinai and Rensselaer investigators address a broad range of conditions in such diverse areas as neuroscience and neurological diseases, genomics, imaging, orthopedics, cancer, and cardiovascular disease.
CBIS is a participant in the UNYTE Translational Research Network, whose mission is to assist faculty and trainees from UNYTE institutions to increase the quality and quantity of translational research in the Upstate New York region. This is accomplished by assessing and accessing expertise, technologies, services, and curricula that might be shared between institutions, to foster collaborative research, reduce resource duplication, and to enhance bidirectional transfer of information between basic and clinical investigators.